Celebrating our 10th anniversary – Unlock our special offer today

CannIntelligence - complete coverage of novel food

CBD products are considered novel foods because there is no history of their consumption prior to May 1997. There is a stringent process for the authorisation of novel foods before they can be launched on the market, which includes an independent safety assessment to ensure the new products are safe for public consumption. All of our content that relates to CBD as a novel food can be accessed from this page.

Many high street CBD products must be removed from sale, research shows

12th April 2022 - Press releases , Resources |

FOR IMMEDIATE RELEASE Many high street CBD products must be removed from sale, research shows The majority of CBD oral products now on the UK market will have to be removed from sale, significantly affecting many retailers and consumers, new analysis from CBD-Intel suggests. CBD-Intel compared the recent Food Standards Agency (FSA) list of oral CBD products which are allowed » Continue Reading.

Italian company gains EU validation for synthetic CBD novel food application

8th July 2021 - News analysis |

The European Commission (EC) has validated a novel food application submitted by the Italian company Farmabios for a synthetic CBD. This is the first step to gaining novel food authorisation from the European Food Safety Authority (EFSA). The company said it had also submitted a similar dossier to the UK Food Standards Agency (FSA) and expects to receive validation there » Continue Reading.

Now that the deadline for applications has passed, when should enforcement action from the UK Food Standards Agency (FSA) be expected?

1st April 2021 - Blogs |

The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the list has been put forward, but the speculation is that it will now more than likely be at least May before it » Continue Reading.

Was the UK FSA decision to make changes to the novel food application timeline really that unexpected?

25th March 2021 - Blogs |

The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires a submission that has been administratively checked (essentially scanned over to make sure all required bits are present) – under the assumption that the application » Continue Reading.

Will the FSA-validated novel food submission list reveal commercially sensitive information?

11th March 2021 - Blogs |

There’s been some worry that the eventual list of brands with a novel food application validated by the UK Food Standards Agency (FSA) will reveal commercially sensitive information such as which brands are currently contracted to which ingredient or white-label goods suppliers. But the FSA has not indicated that such information would be included in any list. And there is » Continue Reading.

US CBD market worth $3bn by 2023

10th March 2021 - Press releases , Resources |

FOR IMMEDIATE RELEASE US CBD market worth $3bn by 2023 New CBD-Intel modelling predicts sharp increase in US CBD market value over next two years The US CBD market will break the $3bn mark in 2023, new CBD-Intel market data modelling predicts, with massive growth stemming from anticipated regulatory changes. CBD-intel predicts US Food and Drug Administration (FDA) rules providing a » Continue Reading.